Insulin Pen Injection Technique: A Comprehensive Guide for Optimal Diabetes Management

Introduction: The Evolution of Insulin Delivery

Diabetes mellitus affects hundreds of millions of people worldwide, with insulin replacement therapy serving as a cornerstone of treatment for both Type 1 and many cases of Type 2 diabetes. The global insulin pen market was valued at approximately USD 10.6 billion in 2025 and is projected to reach USD 25.6 billion by 2034, reflecting a compound annual growth rate of 10.3%. This robust growth underscores the increasing reliance on insulin pens as the preferred delivery device for patients worldwide.

There are two primary treatment modalities for diabetes: oral hypoglycemic agents and injectable insulin therapy. Within insulin therapy, the evolution of injection devices has followed a clear progression—from traditional syringes to insulin high-pressure injectors, insulin pumps, and finally, insulin pens. Although insulin pens have a relatively short history, they were specifically designed to meet the practical needs of diabetes patients.

At Vialab Pharmaceutical Packaging Co., Ltd. , we specialize in the design and manufacture of high-quality drug delivery and packaging components—from disposable and reusable injection pens to sterile vials and tamper-evident caps—all engineered to meet strict pharmaceutical standards. Understanding proper insulin pen injection technique is essential not only for patients but also for healthcare professionals, caregivers, and pharmaceutical partners who develop and supply these critical medical devices.

This article provides a comprehensive, evidence-based guide to insulin pen injection technique, covering device types, proper procedures, common pitfalls, and emerging trends in insulin delivery.

Section 1: Understanding Insulin Pen Devices

1.1 What Is an Insulin Pen?

An insulin pen is a pen-shaped injection device that eliminates the繁琐 process of drawing insulin from a vial using a syringe. It also addresses the social embarrassment patients may feel when injecting in public settings. More importantly, insulin pens provide significant convenience for patients with visual impairment or even blindness.

Insulin pens are generally classified into two main types:

Reusable insulin pens: These pens use replaceable insulin cartridges (penfill cartridges). Once the cartridge is empty, it can be replaced, allowing the pen to be used for many years—potentially even a lifetime.
Disposable (prefilled) insulin pens: These pens come with a prefilled insulin cartridge and are discarded after the cartridge is exhausted or the insulin expires.

In China and many other markets, reusable insulin pens (with replaceable cartridges) remain the most commonly used type.

1.2 Key Advantages of Insulin Pens

Insulin pens offer several distinct advantages:

Ease of use: Insulin is stored in a cartridge connected to a pen body that functions as a dose-dialing device.
Reduced pain: Specially designed disposable needles are ultra-thin and ultra-short, minimizing injection pain.
Portability: Pens are compact and easy to carry.
Cost-effectiveness: Reusable pens allow patients to replace only the cartridge, saving significant costs over time.

1.3 Market Trends and Device Selection

The insulin injection pen and needle market is valued at approximately USD 5.2–6.8 billion in 2025. Disposable insulin pens are expected to grow at 4.5–6.5%, while reusable insulin pens are projected at 4–6%. Smart insulin pens, which integrate digital monitoring and connectivity features, are anticipated to grow at 6–8%.

Recent advancements have shifted focus toward more sustainable, reusable alternatives. Reusable insulin pens can reduce plastic waste by up to 89% and carbon footprint by 40% compared to disposable alternatives. The DISPENSE Study found that replacing plastic insulin pens with metal reusable pens could save over 1.25 million disposable pens annually in a single health district, reducing plastic waste by over 230 tonnes per year.

Section 2: Evidence-Based Insulin Pen Injection Technique

In April 2025, the Forum for Injection Technique and Therapy Expert Recommendations (FITTER)—an international expert panel comprising 16 diabetes specialists from 13 countries—published its updated “FITTER Forward” recommendations in Mayo Clinic Proceedings. This landmark publication represents the first update to global insulin injection best practices in nearly a decade.

2.1 Insulin Storage and Handling

Proper storage is fundamental to insulin efficacy:

Unopened insulin pens and cartridges should be stored in a refrigerator at 2–8°C (36–46°F), away from freezing or food contamination.
Opened (in-use) insulin pens should be stored at room temperature (15–30°C or 59–86°F), away from direct sunlight and extreme heat.
Most opened insulin formulations remain stable at room temperature for 28 days.
Insulin should be brought to room temperature approximately 30 minutes before injection to reduce pain and complications.
Never freeze insulin—freezing destroys the protein structure and renders the medication ineffective.

2.2 Site Selection and Rotation

Proper site selection and systematic rotation are critical for preventing complications:

Recommended injection sites:

Abdomen (the preferred site for fastest absorption)
Thighs (top and outer areas only)
Upper arms (outer area)
Buttocks (upper outer area)

For abdominal injections: Use the area approximately 1 cm above the pubic symphysis, 1 cm below the lowest rib margin, and at least 2.5 cm (approximately 1 inch) away from the navel.

Rotation principles:

Divide the abdomen into four quadrants and use one quadrant per week, rotating clockwise
Divide the thigh and buttock areas into two quadrants
Consecutive injections should be spaced at least 1 cm apart (approximately the width of one adult finger)
If administering multiple injections at the same time (e.g., prandial and basal insulin), use separate injection sites

Systematic site rotation helps prevent lipohypertrophy—a swelling or enlargement of adipocytes that occurs in 30% to 60% of insulin-treated patients. Injecting into lipohypertrophic areas delays insulin absorption and is associated with poor glycemic control.

2.3 Needle Selection

The American Diabetes Association (ADA) recommends using the shortest needles as the first-line choice for all patients:

4-mm pen needles with 32-gauge (32G) diameter are recommended for all adults and children, inserted at a 90° angle without a skin lift in most patients
The FITTER Forward recommendations similarly endorse 4-mm needles for all individuals, regardless of age or BMI
Needles longer than 5 mm are not recommended for any population, as they increase the risk of intramuscular injection
5-mm pen needles may be used as a backup option if 4-mm needles are unavailable

Skin lift considerations:

For most adults using a 4-mm needle, no skin lift is required; the pen should be held at a 90° angle
A skin lift (pinching up approximately 1 inch of skin) may be necessary for:
Patients with low BMI (<19 kg/m²)
Older adults with thin, fragile skin
Pregnant women (especially in second and third trimesters)
Children ≤6 years old
When using 6-mm syringe needles

2.4 Step-by-Step Injection Procedure

Before injection:

Wash hands thoroughly with soap and water
Verify insulin type and dose—double-check the label and prescribed dosage
Correctly install the insulin cartridge (for reusable pens)
For premixed insulin: Gently roll the pen between palms and invert 10 times to ensure proper mixing

Priming the pen:

Install a new pen needle
Prime the pen by dialing 2 units and pressing the injection button until a drop of insulin appears at the needle tip

Injection:

Clean the injection site with 75% alcohol and allow to air dry completely
Determine if skin lift is needed based on needle length and patient characteristics
Insert the needle at a 90° angle perpendicular to the skin surface (for 4–5 mm needles)
Inject insulin slowly with even pressure on the device button

Post-injection:

Wait 10 seconds before withdrawing the needle to ensure complete delivery and prevent insulin leakage
Remove the needle and dispose of it in a sharps container
Do not reuse needles—remove the pen needle after each use

2.5 Priming and Dose Accuracy

Proper priming is essential for dose accuracy:

Newly installed insulin cartridges must be primed before first use
Prime with 2 units as the base unit until insulin appears at the needle tip
Failure to prime affects the injected dose and ultimately impacts blood glucose levels

Modern insulin pens must meet International Organization for Standardization (ISO) 11608-1 requirements for dose accuracy.

Section 3: Common Misconceptions and Errors

3.1 Needle Reuse: A Dangerous Practice

Despite clear recommendations, needle reuse remains widespread globally.

Risks of needle reuse:

Needle tip deformation and blunting, causing increased pain
Bacterial contamination and infection risk
Needle breakage—case reports describe needles breaking off and migrating within the body, requiring surgical removal
Lipohypertrophy and subcutaneous tissue induration
Reduced insulin efficacy and erratic absorption

A systematic meta-analysis identified incorrect injection site rotation (odds ratio 3.75) and needle reuse (odds ratio 3.20) as the strongest risk factors for lipohypertrophy. A US retrospective claims analysis confirmed that pen needle reuse causes tip deformity, breakage, and contamination, and is associated with lipohypertrophy and injection-related pain.

The FITTER guidelines emphasize: Healthcare professionals should educate patients about the consequences of reusing needles and recommend carrying sufficient backup supplies.

3.2 Post-Injection Massage

Incorrect: Rubbing or massaging the injection site after injection.

Correct: Gently press the injection site with a cotton swab for a few seconds. Massaging can accelerate insulin absorption, potentially inducing hypoglycemia, and may cause subcutaneous bleeding.

3.3 Self-Adjustment of Doses

Incorrect: Adjusting insulin doses based on feeling or intuition.

Correct: Follow physician prescriptions strictly, based on regular blood glucose monitoring, and adjust doses only under medical supervision. Medication errors, including insulin administration errors, highlight the need for thorough education in insulin therapy management.

3.4 Insufficient Needle Hold Time

Incorrect: Withdrawing the needle immediately after injection.

Correct: Hold the needle in place for 10 seconds after completing the injection to ensure the full dose is delivered and to prevent insulin leakage.

Section 4: Adverse Reactions and Prevention

4.1 Systemic Adverse Reactions

Hypoglycemia (low blood glucose) is the most common insulin adverse reaction. Causes include:

Excessive insulin dosage
Failure to eat on time after injection
Insufficient food intake
Excessive or prolonged physical activity

Symptoms: Palpitations, hand tremors, sweating. When these occur, consume fast-acting carbohydrates (chocolate, sugary drinks, bananas, etc.).

Other systemic reactions:

Weight gain: Due to insulin’s anabolic effects promoting protein and fat synthesis
Edema: May occur in the face and extremities, usually resolving with continued use
Refractive errors: Blurred vision or远视 may occur initially, resolving as blood glucose stabilizes
Allergic reactions: Rare; may include urticaria, angioedema, or anaphylactic shock

4.2 Local Adverse Reactions

Lipohypertrophy and subcutaneous induration:

The most prevalent local complication of insulin injections
Prevention strategies: systematic site rotation maintaining ≥1 cm spacing between injections, avoidance of affected areas, and single-use needle practices
International guidelines recommend systematic injection site examination every 6 months during the first 2 years of insulin therapy, then annually

Injection site pain:

Ensure alcohol has completely dried before injection
Use shorter, thinner needles (4-mm, 32G recommended)
Never reuse needles

Bleeding and bruising:

Use proper technique and correct skin lift method
Minor bleeding is common—apply gentle pressure with a cotton swab

Section 5: Sustainability and the Future of Insulin Delivery

5.1 Environmental Impact

The environmental footprint of insulin delivery is substantial and growing. Disposable insulin pens are used multiple times, typically over the course of a week, before being discarded, contributing significantly to plastic waste and carbon emissions.

Reusable insulin pens offer a compelling sustainability solution:

Reduce plastic waste by up to 89%
Reduce carbon footprint by 40%
Are either cost-neutral or cheaper than disposable alternatives

The DISPENSE Study demonstrated that replacing plastic insulin pens with metal reusable pens could save over 1.25 million disposable pens annually in a single health district, reducing plastic waste by over 230 tonnes per year. By prioritizing reusable insulin pens, healthcare systems can reduce carbon emissions and clinical waste while maintaining high-quality patient care.

5.2 Emerging Technologies

The insulin delivery landscape continues to evolve with:

Connected/smart insulin pens that capture and store dosing information, integrate with mobile apps, and connect with glucose monitoring devices
Autoinjectors offering highly accurate dosing
User-fillable insulin pens with reusable reservoirs designed for extended use

Conclusion: Precision in Every Injection

Mastering proper insulin pen injection technique is not merely a medical procedure—it is an active, empowering act of self-management that enables individuals with diabetes to enjoy a high quality of life. From correct storage and site rotation to needle selection and dosing accuracy, every detail matters.

At Vialab Pharmaceutical Packaging Co., Ltd. , we understand that the devices patients use every day must meet the highest standards of precision, safety, and reliability. Our injection pens (disposable and reusable) , sterile vials, glass vials and tubes, aluminum and aluminum-plastic caps (tamper-evident) , and customized packaging solutions are engineered with this principle in mind—delivering safety and reliability together for global healthcare partners.

The science of insulin delivery continues to advance, with reusable devices offering both clinical efficacy and environmental sustainability. As the global diabetes population grows, so does the responsibility of pharmaceutical manufacturers, healthcare providers, and patients to ensure that every injection is performed with precision, care, and evidence-based technique.

References: FITTER Forward Expert Recommendations, Mayo Clinic Proceedings (2025); American Diabetes Association Standards of Care in Diabetes (2025); WHO Diabetes Guidelines; various peer-reviewed studies on insulin delivery and injection technique.